smith-magenis syndrome presented by: sara mickelson

25
Smith-Magenis Smith-Magenis Syndrome Syndrome Presented by: Sara Mickelson

Upload: joseph-alexander

Post on 27-Dec-2015

221 views

Category:

Documents


4 download

TRANSCRIPT

Page 1: Smith-Magenis Syndrome Presented by: Sara Mickelson

Smith-Magenis Smith-Magenis SyndromeSyndrome

Presented by: Sara Mickelson

Page 2: Smith-Magenis Syndrome Presented by: Sara Mickelson

What is SMS?What is SMS?

• Syndrome was first described in 1982 by Ann Smith(genetic counselor) and Dr. Ruth Magenis

• Occurs in 1 in 25,000 people• Arises from a spontaneous heterozygous deletion

of part of chromosome 17p11.2 through non-allelic homologous recombination

• No correlation between the size of the deletion and the severity of the phenotype

• People with chromosome 17p11.2 duplicated have a mild phenotype

Page 3: Smith-Magenis Syndrome Presented by: Sara Mickelson

PhenotypesPhenotypes

• Wide range of phenotypes– Mental retardation (IQ 20-78)– Behavioral abnormalities

• Aggressive and Self-inflicted injuries– Self-hugging, polyembolokoilamania

– Sleep disturbances• Melatonin imbalance resembles jet lag

– Delayed speech and motor development– Distinct physical characteristics

Page 4: Smith-Magenis Syndrome Presented by: Sara Mickelson

Journal of Medical Genetics 36

Page 5: Smith-Magenis Syndrome Presented by: Sara Mickelson

Cloning the SMS regionCloning the SMS region

• Common deletion region is ~4Mb as detected by pulsed-field gel electrophoresis and FISH

• Somatic rodent:human hybrid cell lines with the chromosome 17 deletion determined that the critical region is ~1.1Mb

• 16 BACs and 2 PACs were used to assemble the contig transcription map

• Known genes and ESTs were hybridized to EcoRI-digested BACs to map the initial contig

Page 6: Smith-Magenis Syndrome Presented by: Sara Mickelson

Cloning cont.Cloning cont.

• Gene order was determined by human genome project sequence analysis and Southern hybridization for the presence or absence of a certain gene or EST

• Sequence data analysis also identified three low copy repeat sequences

• Somatic cell hybrid analysis revealed that the SMS breakpoints occurred within the distal and proximal SMS-REPs

Page 7: Smith-Magenis Syndrome Presented by: Sara Mickelson

Transcription MapTranscription Map

Figure 1 Lucas et al EJHG 9 (2001)

Page 8: Smith-Magenis Syndrome Presented by: Sara Mickelson

Repeated SequencesRepeated Sequences• Highly homologous (98%) and chromosome 17

contains several Low Copy Repeats which act as substrates for NAHR

• Three low copy repeat sequences: proximal (256kb), middle(241kb), and distal(176kb)

• Middle SMS-REP is an inverted copy• Each SMS-REP contains roughly 14 genes• Critical deletion region occurs between the

proximal and middle SMS-REPs• Divergence from a progenitor 40-65mya

Page 9: Smith-Magenis Syndrome Presented by: Sara Mickelson

Location of SMS-REPsLocation of SMS-REPs

Figure 7 Bi et al. 2002

Page 10: Smith-Magenis Syndrome Presented by: Sara Mickelson

SMS-REPs cont.SMS-REPs cont.

• “hotspots” for NAHR within SMS-REPs• 12kb region within the ~34kb KER gene

cluster• Contains >300bps with perfect identity

along with polymorphic nucleotides • 2.1kb AT rich inverted repeats flank

proximal & middle but not the distal• Hairpin formation initiates NAHR event

Page 11: Smith-Magenis Syndrome Presented by: Sara Mickelson

Figure 2 Bi et al. 2002

Page 12: Smith-Magenis Syndrome Presented by: Sara Mickelson

Figure 5 Bi et al Am.J.Hum.Genet. 73(2003)

Page 13: Smith-Magenis Syndrome Presented by: Sara Mickelson

Cloning cont.

• Sequence analysis also determined that the deletion region contains ~25 genes and 14 ESTs

• Critical region of chromosome 17 contains a high average of gene composition compared to the whole human genome

Page 14: Smith-Magenis Syndrome Presented by: Sara Mickelson

Identifying Candidate GenesIdentifying Candidate Genes

• Looked at genes that are developmentally regulated (mental & behavioral) and expressed in the neural crest (craniofacial & heart development)

• Dosage sensitive

• Transcription factors?– Effect development

Page 15: Smith-Magenis Syndrome Presented by: Sara Mickelson

Candidate GenesCandidate Genes

• Used 6 markers from chromosome 17p11-17p12 regions

• Plasmid clones of 14 ESTs in critical region were sequenced and obtained commercially

• Sequence analysis and tissue expression (Northern blot) was used to identify 6 possible candidate genes within the SMS critical region

Page 16: Smith-Magenis Syndrome Presented by: Sara Mickelson

What are the Candidate Genes?What are the Candidate Genes?

• FLII: actin binding & severing in fly; cell adhesion and protein-protein interaction

• LLGLI: associated with cytoskeleton and serine kinase

• DRG2: GTP binding protein• RASD1: ras related protein in GTPases• NT5M: dephosphorylation of T & U as a

mitochondrial deoxyribonucleotidase• Their roles in SMS are still unknown

Page 17: Smith-Magenis Syndrome Presented by: Sara Mickelson

The Candidate Gene: RAI1The Candidate Gene: RAI1

• Retinoic-acid induced 1 gene is expressed in all adult tissues

• Homologous to mouse Rai1 gene that influences neuronal differentiation

• Haploinsufficiency accounts for facial, otolaryngological, neurological, and behavioral abnormalities

• Heart & renal defects due to other genes within chromosome 17p11.2 since >90% of people with SMS have part of the critical region deleted

Page 18: Smith-Magenis Syndrome Presented by: Sara Mickelson

Lucas et al EJHG 9 (2001)

Page 19: Smith-Magenis Syndrome Presented by: Sara Mickelson

RAI1 cont.RAI1 cont.

• 8kb transcript that is caused by alternative splicing to produce an 1863 AA protein

• Contains CAG repeats & nuclear localization signals

• Sequence similar to transcriptional coactivator TCF20

• RAI1 may interact with other DNA-binding proteins to exert effects on transcription

Page 20: Smith-Magenis Syndrome Presented by: Sara Mickelson

Mutation causes SMS?Mutation causes SMS?

• Mutated RAI1 in three individuals with SMS, but no deletion of critical region

• Deletion in exon 3 of RAI1 on one allele

• Causes the protein to be truncated due to dominant frameshift mutation

• None of the parents carried any of these mutations

Page 21: Smith-Magenis Syndrome Presented by: Sara Mickelson

Mouse knockout

• Human chromosome 17p11.2 is syntenic to the 32-34 cM region of mouse chromosome 11 and the genetic order is highly conserved

• Heterozygous knockout of the syntenic deletion region in mouse using the Cre-loxP site-specific system

• Several SMS phenotypes were observed in mice:– Craniofacial abnormalities, seizures and abnormal

EEGs, weight differences, and reduced male fertility

Page 22: Smith-Magenis Syndrome Presented by: Sara Mickelson

Figure 3 Walz et al. Molecular & Cell Biology 23 (2003)

Page 23: Smith-Magenis Syndrome Presented by: Sara Mickelson

Screening for SMSScreening for SMS

• Screening for SMS among patients with mental retardation of unknown causes

• SMS is often under diagnosed because of subtle and variable expression

• Initially used Southern blotting and dosage comparison between markers, SMS deletion specific and chromosome X control probes

• Confirmatory testing used FISH and/or PCR microsatellitle genotyping

• 1 in 569 were detected to have SMS

Page 24: Smith-Magenis Syndrome Presented by: Sara Mickelson

Figure 5 Struthers et al. J Med Genet 39(2002)

Page 25: Smith-Magenis Syndrome Presented by: Sara Mickelson

ReferencesReferencesAllanson, Judith, Greenberg, Frank, and Smith, Ann. “The face of Smith-Magenis syndrome: a subjective and objective study.” Journal of Medical Genetics 36:394-397, 1999.Lucas, R., Vlangos, C., Das, P., Patel, P., and Elsea, S. “Genomic organization of the ~1.5 Mb Smith-Magenis syndrome critical interval: transcription map, genomic contig, and candidate gene analysis.” European Journal of Human Genetics 9:892-902, 2001.McBride, Gail. “Melatonin disrupts sleep in Smith-Magenis syndrome.” Lancet 354, 1999.Park, S., et al. “Structure and Evolution of the Smtith-Magenis Syndrome repeat Gene clusters, SMS-REPs.” Genome Research 12(5):729-738, 2002.Shaw, C., Weimin, B., and Lupski, J. “Genetic proof of unequal meiotic crossovers in reciprocal deletion and duplication of 17p11.2.” American Journal of Human Genetics 71:1072-1081, 2002.Slager, Rebecca E., Newton, Tiffany L., Vlangos, Christopher N., Finucane, Brenda, and Elsea, Sarah H. “Mutations in RAI1 associated with Smith-Magenis syndrome.” Nature Genetics 33(4): 466-468, 2003. Struthers, J. L., Carson, N., McGill, M., Khalifa, M. M. “Molecular screening for Smith-Magenis syndrome among patients with mental retardation of unknown cause.” Journal of Medical Genetics 39(59).Walz, K., et al. “Modeling del(17)(p11.2p11.2) and dup (17)(p11.2p11.2) contiguous gene syndromes by chromosome engineering in mice: Pheontypic consequences of gene dosage imbalance.” Molecular and Cell Biology 23(10):3646-3655, 2003.Weimin, B., Park, S., Shaw, C., Withers, M., Patel, P., and Lupski, J. “Reciprocal Crossovers and a Positional Preference for Strand Exchange in recombination events resulting in deletion or duplication of chromosome 17p11.2.” American Journal of Human Genetics 73:1302-1315, 2003. Weimin B., Yan, J., Stankiewicz, P., et al. “Genes in a Refined Smith-Magenis Syndrome Critial Deletion Interval of Chromosome 17p11.2 and the syntenic region of the mouse.” Genome Research 12(5):71-28, 2002.